Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. G. Barr, G. S. Lovasi, P. L. Enright, J. A. Hardie, R. A. Kronmal, P. Lange, A. B. Newman, J. Vestbo (New York, NY, Tucson, AZ, Seattle, WA, Pittsburgh, PA, United States Of America; Bergen, Norway; Hvidovre, Denmark). Spirometry for the risk stratification of cardiovascular disease among the elderly. Eur Respir J 2007; 30: Suppl. 51, 1923

Member's Comments

No comment yet.

Related content which might interest you: OSA and cardiovascular risk in women Source: 5th Sleep and Breathing Conference Year: 2019 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 Prevalence of COPD in the general population according to cardiovascular risk factors Source: Eur Respir J 2007; 30: Suppl. 51, 778s Year: 2007 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Source: Eur Respir J 2015; 46: 846-849 Year: 2015 Prevalence of cardiovascular disease in COPD patients in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Correlates and assessment of excess cardiovascular risk in bronchiectasis Source: Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017 Year: 2017 Global cardiovascular disease risk in U.S. adults by severity and presence of COPD Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Prevalence of undiagnosed COPD in patients with established cardiovascular diseases Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Obesity, smoking and gender type as cardiovascular risk factors among COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications Source: International Congress 2015 – COPD: notable points Year: 2015 Cardiovascular risk detection in COPD Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019